V(D)J recombinase-mediated TCR β locus gene usage and coding joint processing in peripheral T cells during perinatal and pediatric development

Journal of Immunology

Volumn 189, Issue 5, 2012, Pages 2356-2364

  Murray, Janet M ^a   Messier, Terri ^b   Rivers, Jami ^b   O'Neill, J Patrick ^b   Walker, Vernon E ^a   Vacek, Pamela M ^b   Finette, Barry A ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINASE; T LYMPHOCYTE RECEPTOR BETA CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR;

AGE DISTRIBUTION; ARTICLE; CHILD; CHILD DEVELOPMENT; CODING JOINT PROCESSING; ENZYME ACTIVITY; FEMALE; FETUS DEVELOPMENT; GENE; GENE REARRANGEMENT; GENE SEQUENCE; GENE USAGE; HUMAN; HUMAN CELL; INFANT; MALE; MOLECULAR GENETICS; NEWBORN; NUCLEOTIDE SEQUENCE; PERINATAL DEVELOPMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RECOMBINATION SIGNAL SEQUENCE; SCHOOL CHILD; SEX DIFFERENCE; T LYMPHOCYTE; TCR BETA GENE; COHORT ANALYSIS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE LOCUS; GENETICS; IMMUNOGLOBULIN STRUCTURE; IMMUNOLOGY; PHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; T LYMPHOCYTE SUBPOPULATION;

CHILD; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REARRANGEMENT, T-LYMPHOCYTE; GENETIC LOCI; HUMANS; IMMUNOGLOBULIN JOINING REGION; INFANT, NEWBORN; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTE SUBSETS; VDJ RECOMBINASES;

EID: 84865437254     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200382     Document Type: Article

References (45)

1. Alt, F. W., E. M. Oltz, F. Young, J. Gorman, G. Taccioli, and J. Chen. 1992. VDJ recombination. Immunol. Today 13: 306-314.
2. Fugmann, S. D., A. I. Lee, P. E. Shockett, I. J. Villey, and D. G. Schatz. 2000. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu. Rev. Immunol. 18: 495-527.
3. Gellert, M. 2002. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu. Rev. Biochem. 71: 101-132.
4. Folch, G., and M. P. Lefranc. 2000. The human T cell receptor beta diversity (TRBD) and beta joining (TRBJ) genes. Exp. Clin. Immunogenet. 17: 107-114.
5. Folch, G., and M. P. Lefranc. 2000. The human T cell receptor beta variable (TRBV) genes. Exp. Clin. Immunogenet. 17: 42-54.
6. Krangel, M. S. 2003. Gene segment selection in V(D)J recombination: accessibility and beyond. Nat. Immunol. 4: 624-630.
7. Manfras, B. J., D. Terjung, and B. O. Boehm. 1999. Non-productive human TCR beta chain genes represent V-D-J diversity before selection upon function: insight into biased usage of TCRBD and TCRBJ genes and diversity of CDR3 region length. Hum. Immunol. 60: 1090-1100.
8. Lewis, S. M. 1994. The mechanism of V(D)J joining: lessons from molecular, immunological, and comparative analyses. Adv. Immunol. 56: 27-150.
9. Nadel, B., and A. J. Feeney. 1997. Nucleotide deletion and P addition in V(D)J recombination: a determinant role of the coding-end sequence. Mol. Cell. Biol. 17: 3768-3778.
10. Gellert, M. 1997. Recent advances in understanding V(D)J recombination. Adv. Immunol. 64: 39-64.
11. Kim, D. R., S. J. Park, and M. A. Oettinger. 2000. V(D)J recombination: site-specific cleavage and repair. Mol. Cells 10: 367-374.
12. Candéias, S., K. Muegge, and S. K. Durum. 1996. Junctional diversity in signal joints from T cell receptor beta and delta loci via terminal deoxynucleotidyl transferase and exonucleolytic activity. J. Exp. Med. 184: 1919-1926.
13. Lieber, M. R., J. E. Hesse, K. Mizuuchi, and M. Gellert. 1988. Lymphoid V(D)J recombination: nucleotide insertion at signal joints as well as coding joints. Proc. Natl. Acad. Sci. USA 85: 8588-8592.
14. Murray, J. M., J. P. O'Neill, T. Messier, J. Rivers, V. E. Walker, B. McGonagle, L. Trombley, L. G. Cowell, G. Kelsoe, F. McBlane, and B. A. Finette. 2006. V(D)J recombinase-mediated processing of coding junctions at cryptic recombination signal sequences in peripheral T cells during human development. J. Immunol. 177: 5393-5404.
15. Finette, B. A., T. Poseno, and R. J. Albertini. 1996. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children. Cancer Res. 56: 1405-1412.
16. Fuscoe, J. C., L. J. Zimmerman, M. J. Lippert, J. A. Nicklas, J. P. O'Neill, and R. J. Albertini. 1991. V(D)J recombinase-like activity mediates hprt gene deletion in human fetal T-lymphocytes. Cancer Res. 51: 6001-6005.
17. Finette, B. A., L. M. Sullivan, J. P. O'Neill, J. A. Nicklas, P. M. Vacek, and R. J. Albertini. 1994. Determination of hprt mutant frequencies in T-lymphocytes from a healthy pediatric population: statistical comparison between newborn, children and adult mutant frequencies, cloning efficiency and age. Mutat. Res. 308: 223-231.
18. O'Neill, J. P., M. J. McGinniss, J. K. Berman, L. M. Sullivan, J. A. Nicklas, and R. J. Albertini. 1987. Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. Mutagenesis 2: 87-94.
19. Abramson, L. S., R. J. Albertini, L. M. Pachman, and B. A. Finette. 1999. Association among somatic HPRT mutant frequency, peripheral blood Tlymphocyte clonality, and serologic parameters of disease activity in children with juvenile onset dermatomyositis. Clin. Immunol. 91: 61-67.
20. Kendall, H. E., P. M. Vacek, J. L. Rivers, S. C. Rice, T. L. Messier, and B. A. Finette. 2006. Analysis of genetic alterations and clonal proliferation in children treated for acute lymphocytic leukemia. Cancer Res. 66: 8455-8461.
21. Zuleger, C. L., M. D. Macklin, B. L. Bostwick, Q. Pei, M. A. Newton, and M. R. Albertini. 2011. In vivo 6-thioguanine-resistant T cells from melanoma patients have public TCR and share TCR beta amino acid sequences with melanoma-reactive T cells. J. Immunol. Methods 365: 76-86.
22. Garderet, L., N. Dulphy, C. Douay, N. Chalumeau, V. Schaeffer, M. T. Zilber, A. Lim, J. Even, N. Mooney, C. Gelin, et al. 1998. The umbilical cord blood alphabeta T-cell repertoire: characteristics of a polyclonal and naive but completely formed repertoire. Blood 91: 340-346.
23. Jores, R., and T. Meo. 1993. Few V gene segments dominate the T cell receptor beta-chain repertoire of the human thymus. J. Immunol. 151: 6110-6122.
24. Freeman, J. D., R. L. Warren, J. R. Webb, B. H. Nelson, and R. A. Holt. 2009. Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing. Genome Res. 19: 1817-1824.
25. Malhotra, U., R. Spielman, and P. Concannon. 1992. Variability in T cell receptor V beta gene usage in human peripheral blood lymphocytes. Studies of identical twins, siblings, and insulin-dependent diabetes mellitus patients. J. Immunol. 149: 1802-1808.
26. van den Beemd, R., P. P. Boor, E. G. van Lochem, W. C. Hop, A. W. Langerak, I. L.Wolvers-Tettero, H. Hooijkaas, and J. J. van Dongen. 2000. Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry 40: 336-345.
27. Wedderburn, L. R., A. Patel, H. Varsani, and P. Woo. 2001. The developing human immune system: T-cell receptor repertoire of children and young adults shows a wide discrepancy in the frequency of persistent oligoclonal T-cell expansions. Immunology 102: 301-309.
28. Gauss, G. H., and M. R. Lieber. 1996. Mechanistic constraints on diversity in human V(D)J recombination. Mol. Cell. Biol. 16: 258-269.
29. Repasky, J. A., E. Corbett, C. Boboila, and D. G. Schatz. 2004. Mutational analysis of terminal deoxynucleotidyltransferase-mediated N-nucleotide addition in V(D)J recombination. J. Immunol. 172: 5478-5488.
30. George, J. F., Jr., and H. W. Schroeder, Jr. 1992. Developmental regulation of D beta reading frame and junctional diversity in T cell receptor-beta transcripts from human thymus. J. Immunol. 148: 1230-1239.
31. Collins, A. M., M. Ikutani, D. Puiu, G. A. Buck, A. Nadkarni, and B. Gaeta. 2004. Partitioning of rearranged Ig genes by mutation analysis demonstrates D-D fusion and V gene replacement in the expressed human repertoire. J. Immunol. 172: 340-348.
32. Corbett, S. J., I. M. Tomlinson, E. L. Sonnhammer, D. Buck, and G.Winter. 1997. Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination. J. Mol. Biol. 270: 587-597.
33. +/+ mice. J. Immunol. 177: 1120-1128.
34. Yamada, M., R. Wasserman, B. A. Reichard, S. Shane, A. J. Caton, and G. Rovera. 1991. Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J. Exp. Med. 173: 395-407.
35. Souto-Carneiro, M. M., N. S. Longo, D. E. Russ, H. W. Sun, and P. E. Lipsky. 2004. Characterization of the human Ig heavy chain antigen binding complementarity determining region 3 using a newly developed software algorithm, JOINSOLVER. J. Immunol. 172: 6790-6802.
36. Chao, T. C. 1996. Female sex hormones and the immune system. Changgeng Yi Xue Za Zhi 19: 95-106.
37. Malleson, P. N., M. Y. Fung, and A. M. Rosenberg. 1996. The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry. J. Rheumatol. 23: 1981-1987.
38. Igarashi, H., T. Kouro, T. Yokota, P. C. Comp, and P. W. Kincade. 2001. Age and stage dependency of estrogen receptor expression by lymphocyte precursors. Proc. Natl. Acad. Sci. USA 98: 15131-15136.
39. Finette, B. A., H. Kendall, and P. M. Vacek. 2002. Mutational spectral analysis at the HPRT locus in healthy children. Mutat. Res. 505: 27-41.
40. Chen, C.-L., J. C. Fuscoe, Q. Liu, and M. V. Relling. 1996. Etoposide causes illegitimate V(D)J recombination in human lymphoid leukemic cells. Blood 88: 2210-2218.
41. Finette, B. A., J. P. O'Neill, P. M. Vacek, and R. J. Albertini. 1998. Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke. Nat. Med. 4: 1144-1151.
42. Lipkowitz, S., V. F. Garry, and I. R. Kirsch. 1992. Interlocus V-J recombination measures genomic instability in agriculture workers at risk for lymphoid malignancies. Proc. Natl. Acad. Sci. USA 89: 5301-5305.
43. Pinsonneault, R. L., P. M. Vacek, J. P. O'Neill, and B. A. Finette. 2007. Induction of V(D)J-mediated recombination of an extrachromosomal substrate following exposure to DNA-damaging agents. Environ. Mol. Mutagen. 48: 440-450.
44. Strick, R., P. L. Strissel, S. Borgers, S. L. Smith, and J. D. Rowley. 2000. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc. Natl. Acad. Sci. USA 97: 4790-4795.
45. Finette, B. A. 2006. Analysis of mutagenic V(D)J recombinase mediated mutations at the HPRT locus as an in vivo model for studying rearrangements with leukemogenic potential in children. DNA Repair (Amst.) 5: 1049-1064.